← Back to Search

Airway Opening Techniques for Obstructive Sleep Apnea (DISE-CAD Trial)

N/A
Recruiting
Led By Raj C Dedhia, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (≥ 22yrs)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 3 months of enrollment
Awards & highlights

DISE-CAD Trial Summary

This trial is looking at how different tongue muscles help keep the airway open during sleep, to see which ones are most important.

Who is the study for?
This trial is for adults over 22 with obstructive sleep apnea who have an MRI-safe Inspire hypoglossal nerve stimulator and use it more than 20 hours a week. It's not for those with MRI contraindications, certain Inspire models, a recent sleep-related driving incident, trouble sleeping on their back or in labs, or pregnant women.Check my eligibility
What is being tested?
The study tests how specific tongue muscles help keep the airway open during sleep using treatments like lingual muscle stimulation and tongue exercises. Techniques include MRIs to view muscles and overnight studies (PSG) to monitor sleep and breathing.See study design
What are the potential side effects?
Possible side effects may include discomfort from the tongue exercises or muscle stimulation, anxiety or claustrophobia from MRI procedures, and potential sleep disturbances during overnight monitoring.

DISE-CAD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 22 years old or older.

DISE-CAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 3 months of enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 months of enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amax
Pharyngeal compliance
Segmental Airway Resistances
+1 more
Secondary outcome measures
Digital Morphometrics
Tongue Force

DISE-CAD Trial Design

1Treatment groups
Experimental Treatment
Group I: Lingual Muscle Stimulation PatientsExperimental Treatment7 Interventions
DISE

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,882,109 Total Patients Enrolled
Raj C Dedhia, MDPrincipal InvestigatorUniversity of Pennsylvania

Media Library

Lingual Muscle Stimulation Clinical Trial Eligibility Overview. Trial Name: NCT04322097 — N/A
Obstructive Sleep Apnea Research Study Groups: Lingual Muscle Stimulation Patients
Obstructive Sleep Apnea Clinical Trial 2023: Lingual Muscle Stimulation Highlights & Side Effects. Trial Name: NCT04322097 — N/A
Lingual Muscle Stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04322097 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of participants involved in this research?

"Affirmative. According to clinicaltrials.gov, this research is currently recruiting test subjects. This study was initially published on June 3rd 2020 and edited for the last time on November 14th 2022 with a target of 100 participants from one site."

Answered by AI

Are any new participants being enrolled in this research at the moment?

"Affirmative. Clinicaltrials.gov attests to this trial's active recruitment of participants, which began on June 3rd 2020 and was last revised November 14th 2022. The researchers are looking for 100 individuals across a single site."

Answered by AI
~19 spots leftby Apr 2025